Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....
Shimadzu Corporation, a global leader in the precision instrumentation industry, and Diagnostics Development Hub (DxD Hu...
Italy-based Tethis S.p.A., a pioneer in standardised liquid biopsy platform development, and Sheba Medical Center, ...
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
The offering includes: €850 million floating rate notes, due March 2027, bearing interest at 3-month Eur...
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...
SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...
China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (B...
Taiwan-based Health2Sync, a leading digital health company specialising in chronic disease management, has raised over $...
Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...
Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...
Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload an...
It is never lost on me or my team at MTPConnect that there is a paucity of funding allocated to women’s health res...
This year marks the 10th anniversary of the International Day of Women in STEM, highlighting a decade of progress in clo...
Degrader-antibody conjugates (DACs) represent a natural evolution in targeted precision medicines for oncology and other...
